Interactions of olopatadine and selected antihistamines with model and natural membranes

References

• Mota I, da Silva WD. The anti-anaphylactic and histamine releasing properties of the anti-histamines: their effect on mast cells. Br J Pharmacol. 1960;15:396–404.
   Web of Science ®Google Scholar
• Lichtenstein LM, Gillespie E. The effects of H, and 1-12 antihistamines on allergic histamine release and its inhibition by histamine. J Pharmacol Exp Ther. 1975;192:44.1–450.
   PubMed Web of Science ®Google Scholar
• Church MK, Gradidge CE Inhibition of histamine release from human lung in vitro by antihistamines and related drugs. Br J Pharmacol. 198o;69:663–667.
   Google Scholar
• Frisk-Holmberg M, Van der Kleijn E. The relationship between the lipophylic nature of tricyclic neuroleptics and anti-depressants and histamine release. Eur J Pharmacol. 1972;18:139–147.
   Google Scholar
• Kazimierczak W, Peret M, Maslinski C. The action of local anaesthetics on histamine release. Biochem Pharmacol. 1976;25:1747-175o.
   Google Scholar
• Seeman P. The membrane actions of anaesthetics and tranquilizers. Pharmacol Rev. 1972;24:583–655.
   PubMed Web of Science ®Google Scholar
• Felmeister A. Relationships between surface activity and biological activity of drugs. J Pharm ScL 1972;61:151–164.
   PubMed Web of Science ®Google Scholar
• Attwood D, Florence AT. Surface activity and colloidal properties of drugs and naturally occurring substances. In: Surfactant systems. New York: Chapman and Hall, 1983; 124–228.
   Google Scholar
• Yanni JM, Stephens DJ, Miller ST, Weimer LK, Graff G, Parnell D, Lang LS, Spellman JM, Brady MT, Gamache DA. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent. J Ocular Pharmacol Ther. 1996;12:389–400.
   PubMed Web of Science ®Google Scholar
• Sharif NA, Xu SX, Miller ST, Gamache DA, Yanni JM. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases. J Pharmacol Exp Ther. 1996;278: 1252–1261.
   Google Scholar
• Yanni JM, Miller ST, Gamache DA, Spellman JM, Xu S, Sharif NA. Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells. Ann Allergy Asthma ImmunoL 1997;79:541–545.
   PubMed Web of Science ®Google Scholar
• Abelson MB. Evaluation of olopatadine, a new ophthalmic antiallergic agent with dual activity, using the conjunctival allergen challenge model. Ann Allergy Asthma ImmunoL 1998;81:211–218.
   PubMed Web of Science ®Google Scholar
• Ishii H, Sasaki Y, Manabe H, Ikemura T, Sato H, Ichikawa S, Shiozaki S, Kitamura S, Ohmori K. General pharmacology of KW-4679 an antiallergic drug (1st report) — Effects on central nervous system, autonomic nervous system and peripheral nervous system. Clin Pharmacol Ther. 1995;5: 1421–1440.
   Google Scholar
• Kosaka Y, Toda Y, Ishii A. Effect of KW-4679 on cyclic AMP content in rat peritoneal mast cells. Kyowa Hakko Kogyo, Ltd. Internal Report 87-142(Y) 1987.
   Google Scholar
• Attwood D, Udeala OK. The interaction of antihistamines with lecithin monolayers. J Pharm Pharmacol. 1975;27:806–810.
   PubMed Web of Science ®Google Scholar
• Attwood D, Udeala OK. The surface activity of some antihistamines at the air-solution interface. J Pharm Pharmacol. 1975;27:754–758.
   PubMed Web of Science ®Google Scholar
• Seeman P, Weinstein J. Erythrocyte membrane stabilization by tranquilizers and antihistamines. Biochem Pharmacol. 1966;15: 1737–1752.
   Web of Science ®Google Scholar
• Brockman H, Graff G, Spellman J, Yanni J. A comparison of the effects of olopatadine and ketotifen on model membranes. Acta Ophthamol Scand. 2000;78: 10–15.
   Google Scholar
• Adamson AW. The solid-liquid interface. Adsorption from solution. In: Physical chemistry of surfaces. 2nd ed. New York: Interscience Publishers, 1967; 397–435.
   Google Scholar
• Chattoraj DK, Birdi KS. Adsorbed monolayers and energies of adsorption. In: Adsorption and the Gibbs surface excess. New York: Plenum Press, 1984; 133–177.
   Google Scholar
• Keukens EAJ, De Vrije T, Jansen LAM, De Boer H, Janssen M, De Kroon AIPM, Jongen WMF, De Kruijff B. Glycoalkaloids selectively permeabilize cholesterol containing biomembranes. Biochim Biophys Acta 1996;1279:243–250.
   PubMed Web of Science ®Google Scholar
• Kates M. Lipid extraction procedures. In: Work TS, Work E, editors. Vol. 3, Part II of Laboratory Techniques in Biochemistry and Molecular Biology. Techniques of lipidology: isolation, analysis and identification of lipids. Amsterdam: North-Holland Publishing, 1972; 347–353.
   Google Scholar
• Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem. 1959;234:466–469.
   PubMed Web of Science ®Google Scholar
• Fischer H, Gottschlich R, Seelig A. Blood-brain barrier permeation: molecular parameters governing passive diffusion. J Membr Biol. 1998;165:201–211.
   Google Scholar
• Marsh D. Lateral pressure in membranes. Biochim Biophys Acta. 1996 1286:183–223.
   PubMed Web of Science ®Google Scholar
• MacDonald RC. The relationship and interactions between lipid bilayers vesicles and lipid monolayers at the air/water interface. In: Rosoff M, editor. Vesicles. New York: Marcel Dekker, 1996; 3–48.
   Google Scholar
• Pethica BA. The thermodynamics of monolayer penetration at constant area. Faraday Soc Trans. 1955;51: 1402–1411.
   Google Scholar
• Cunningham BA, Tsujita T, Brockman HL. Enzymatic and physical characterization of diacylglycerol-phosphatidylcholine interactions in bilayers and monolayers. Biochemistry. 1989;8: 32–40.
   Google Scholar
• Pethica BA, Schulman JH. The physical chemistry of haemolysis by surface-active agents. Biochem J. 1953;53:177–185.
   PubMed Web of Science ®Google Scholar
• Mayer LD, Nelsestuen GL, Brockman HL. Prothrombin association with phospholipid monolayers. Biochemistry. 1983;22: 316–321.
   Google Scholar
• Zwaal RFA, Roelofsen B, Comfurius P, Van Deenen LLM. Organization of phospholipids in human red cell membranes as detected by the action of various purified phospholipases. Biochem Biophys Acta. 1975406: 83–96.
   Google Scholar
• Berdy GJ, Spangler DL, Bensch G, Berdy SS, Brusatti RC. Comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge model. Guth Ther. 2000;22: 826–833.
   Google Scholar
• Aguilar AJ. Comparative study of clinical efficacy and tolerance in seasonal allergic conjunctivitis management with 0.1% olopatadine hydrochloride versus 0.05% ketotifen fumarate. Acta Ophthalmol Scand. 2000;78:57–60.
   Google Scholar